Reaction
Cerebral Artery Embolism reporting signals
As of the last recalculation, Cerebral Artery Embolism appears in 1,209 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is POSACONAZOLE DELAYED-RELEASE (PRR 23.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Posaconazole Delayed-Release | 15 | 23.8 | 23.8 |
| Amphotericin B | 17 | 23.7 | 23.7 |
| Ganciclovir | 12 | 20.4 | 20.4 |
| Ganciclovir Sodium | 12 | 19.7 | 19.7 |
| Alteplase | 15 | 17.4 | 17.4 |
| Posaconazole | 15 | 16.1 | 16.1 |
| Cefepime | 13 | 15.8 | 15.8 |
| Heparin Sodium | 12 | 15.2 | 15.2 |
| Voriconazole Injection | 18 | 14.5 | 14.5 |
| Cefepime Hydrochloride | 13 | 14.0 | 14.0 |
| Rivaroxaban | 142 | 13.2 | 13.2 |
| Dabigatran Etexilate Mesylate | 52 | 12.8 | 12.8 |
| Dabigatran Etexilate | 55 | 12.7 | 12.7 |
| Febuxostat Tablets 40 Mg | 7 | 11.9 | 11.9 |
| Febuxostat Tablets 80 Mg | 7 | 11.9 | 11.9 |
| Sevoflurane | 5 | 10.4 | 10.4 |
| Voriconazole | 18 | 10.3 | 10.3 |
| Gefitinib | 5 | 9.6 | 9.6 |
| Tolvaptan | 8 | 9.5 | 9.5 |
| Drospirenone And Ethinyl Estradiol | 14 | 5.5 | 5.5 |
| Ranibizumab | 6 | 3.9 | 3.9 |
| Remdesivir | 3 | 3.9 | 3.9 |